Bio-Path Holdings, Inc. (BPTH) Social Stream



Bio-Path Holdings, Inc. (BPTH): $2.21

0.04 (+1.84%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BPTH to Watchlist
Sign Up

Industry: Biotech


Ranked

of 489

in industry

BIO-PATH HOLDINGS INC (BPTH) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BPTH.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-14 1 $13 $12 $12.5 $2.07 503.86%
2022-05-17 2 $13 $12 $12.5 $2.07 503.86%
2022-11-15 2 $13 $9 $11 $2.07 431.4%

The Trend in the Analyst Price Target


BPTH's average price target has moved down $7 over the prior 30 months.

BPTH reports an average of 327.99% for its upside potential over the past 35 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-14 1 13 12 12.5 3.06 308.5%
2022-05-17 2 13 12 12.5 3.11 301.93%
2022-05-18 2 13 9 11.0 3.11 253.7%
2022-08-17 2 13 9 11.0 3.94 179.19%
2022-11-15 2 13 9 11.0 1.53 618.95%

BPTH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 35 weeks, BPTH's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BPTH as an investment opportunity.

  • BIO-PATH HOLDINGS INC's number of analysts covering the stock is higher than 6.9% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, BIO-PATH HOLDINGS INC's upside potential (average analyst target price relative to current price) is greater than 279.17% of them.
  • In terms of how BIO-PATH HOLDINGS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 65.51% of that group.
  • BIO-PATH HOLDINGS INC's average analyst price target is greater than 67.28% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BIO-PATH HOLDINGS INC are GALT, ONTX, and LUMO.

Make investment decisions regarding BPTH using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6753 seconds.